机译:关节黏附分子-A的上调是高血压的预后标志
1School of Physiology and Pharmacology, Bristol Heart Institute, Medical Sciences Building, University of Bristol, Bristol BS8 1TD, UK 2Cardiovascular Division, Department of Physiology, Federal University of São Paulo, Santos, São Paulo, Brazil 3Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK 4IFOM, Institute FIRC of Molecular Oncology, Milan, Italy 5Department of Physiology, Wakayama Medical University School of Medicine, Wakayama City, Japan 6Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, University of Bristol, Bristol, UK;
机译:关节黏附分子-A的上调是高血压的预后标志
机译:高血压患者血浆可溶性F11受体/连接粘附分子-A(F11R / JAM-A)升高。
机译:结粘附分子-A,JAM-A,是一种用于长期再生造血干细胞的新型细胞表面标记。
机译:脑溶素对中暑后糖尿病和高血压患者血脑屏障破坏,神经病理学及一氧化氮合酶和血氧合酶上调的神经保护作用
机译:通过连接黏附分子-a(jam-a)调节成纤维细胞生长因子2(fgf-2)和血管内皮生长因子-a(vegf-a)依赖性血管生成的机制。
机译:关节黏附分子-A的上调是高血压的预后标志
机译:关节黏附分子-A的上调是高血压的预后标志